Estadísticas

 array:18 [
  "pii" => "13143256"
  "issn" => "02104806"
  "estado" => "S300"
  "fechaPublicacion" => "2009-05-01"
  "documento" => "article"
  "subdocumento" => "fla"
  "cita" => "Actas Urol Esp. 2009;33:609-14"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 2657
    "formatos" => array:3 [
      "EPUB" => 7
      "HTML" => 1613
      "PDF" => 1037
    ]
  ]
  "itemAnterior" => array:14 [
    "pii" => "13143257"
    "issn" => "02104806"
    "estado" => "S300"
    "fechaPublicacion" => "2009-05-01"
    "documento" => "article"
    "subdocumento" => "fla"
    "cita" => "Actas Urol Esp. 2009;33:603-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 3918
      "formatos" => array:3 [
        "EPUB" => 9
        "HTML" => 1487
        "PDF" => 2422
      ]
    ]
    "es" => array:9 [
      "idiomaDefecto" => true
      "titulo" => "Recidiva local del tumor renal"
      "tienePdf" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "603"
          "paginaFinal" => "608"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:2 [
        "es" => true
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Emilio García Galisteo, P. Morales Jiménez, D. Hernández Alcaraz, Víctor Baena González"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Emilio"
              "apellidos" => "García Galisteo"
            ]
            1 => array:2 [
              "Iniciales" => "P."
              "apellidos" => "Morales Jiménez"
            ]
            2 => array:2 [
              "Iniciales" => "D."
              "apellidos" => "Hernández Alcaraz"
            ]
            3 => array:2 [
              "nombre" => "Víctor"
              "apellidos" => "Baena González"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13143257?idApp=UINPBA00004N"
    "url" => "/02104806/0000003300000005/v0_201607111116/13143257/v0_201607111120/es/main.assets"
  ]
  "es" => array:10 [
    "idiomaDefecto" => true
    "titulo" => "Nuevas terapias de diana celular: indicaciones, resultados ytolerabilidad"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "609"
        "paginaFinal" => "614"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Joaquim Bellmunt, Antoni Gelabert-Mas"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Joaquim"
            "apellidos" => "Bellmunt"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Antoni"
            "apellidos" => "Gelabert-Mas"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Servicio de Oncología Médica (GU y GI)."
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Servicio y Cátedra de Urología. Hospital del Mar. Barcelona, España"
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
        ]
      ]
    ]
    "pdfFichero" => "292v33n05a13143256pdf001.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec689524"
          "palabras" => array:1 [
            0 => "C&#225;ncer renal metast&#225;sico&#44; Terapia diana celular&#44; Sunitinib&#44; Sorafenib&#44;Temsirolimus&#44; Overolimus"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec689525"
          "palabras" => array:6 [
            0 => "Metastatic renal cancer"
            1 => "Cell targeted therapy"
            2 => "Sunitinib"
            3 => "Sorafenib"
            4 => "Temsirolimus"
            5 => "Overolimus"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:1 [
        "resumen" => "Los avances en la comprensi&#243;n de la biolog&#237;amolecular del RCC ha dado lugar al desarrollo detratamientos biol&#243;gicos dirigidos &#40;terapias diana&#41;que representan&#44; por vez primera en m&#225;s de quincea&#241;os de tan solo disponer de las citocinas comoarma terap&#233;utica&#44; un avance significativo en el tratamientode esta enfermedad&#44; con una mejoraimportante en la supervivencia libre de enfermedady con algunos f&#225;rmacos&#44; de la supervivencia global&#46;Asimismo&#44; el perfil de toxicidad con respecto a lostratamientos considerados est&#225;ndar como las citoquinashan mejorado de forma ostensible&#46;"
      ]
      "en" => array:1 [
        "resumen" => "Advances in understanding of the molecular biology of RCC have led to development of targeted biological treatments &#40;targeted therapies&#41; which&#44; after more than 15 years in which the only therapeutic weapons available were cytokines&#44; represent a significant advance in the treatment of this disease&#44; resulting in a significant improvement in disease-free survival and&#44; with some drugs&#44; in overall survival&#46; The toxicity profile has also markedly improved as compared to standard treatments such as cytokines&#46;"
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02104806/0000003300000005/v0_201607111116/13143256/v0_201607111120/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "55588"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Original"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02104806/0000003300000005/v0_201607111116/13143256/v0_201607111120/es/292v33n05a13143256pdf001.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/13143256?idApp=UINPBA00004N"
  "pdfAlternativo" => array:1 [
    0 => array:3 [
      "idioma" => "en"
      "documentoPdf" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/file/02104806/addon/13143256/S300/en/292v33n05a13143256pdf001_2.pdf"
      "portada" => "292v33n05a13143256pdf001_2.png"
    ]
  ]
]